Sfoglia per Autore
Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel
2024-01-01 Jommi, Claudio; Patarnello, Francesca; Bianchi, Cosetta; Buzzetti, Giuliano
Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy
2024-01-01 Bolcato, Matteo; Jommi, Claudio
Regional Formularies in Italy: current state and future perspectives
2024-01-01 Bortolami, Alberto; Jommi, Claudio; Bresciani, Filippo; Piccoli, Luca; Sangiorgi, Elisa; Scroccaro, Giovanna
Content validity of the EQ-HWB and EQ-HWB-S in a sample of Italian patients, informal caregivers and members of the general public
2024-01-01 Masutti, Sara; Falivena, Camilla; Purba, Fredrick Dermawan; Jommi, Claudio; Mukuria, Clara; Finch, Aureliano Paolo
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
2024-01-01 Rossini, Elvio Emanuele; Galeone, Carlotta; Lucchetti, Chiara; Jommi, Claudio
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
2024-01-01 Cavallo, Maria Caterina; Cavazza, Marianna; Bonifazi, Francesca; Casadei, Beatrice; Cutini, Ilaria; Tonietti, Barbara; Saccardi, Riccardo; Zinzani, Pierluigi; Jommi, Claudio
Early access programs for medicines: a reform proposal for the Italian National Health Service
2024-01-01 Popoli, Patrizia; Giuliani, Giovanni; Cavaliere, Arturo; Jommi, Claudio
The economic impact of 14 compassionate use programs for medicines in Italy, in the perspective of the National Health Service
2024-01-01 Jommi, Claudio; Pantellini, Federico; Giuliani, Giovanni; Cavazza, Marianna
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe
2023-01-01 Jommi, Claudio; Bertolani, Arianna; Armeni, Patrizio; Costa, Francesco; Otto, Monica
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access
2023-01-01 Giovannelli, Lorella; Bari, Elia; Jommi, Claudio; Tartara, Fulvio; Armocida, Daniele; Garbossa, Diego; Cofano, Fabio; Torre, Maria Luisa; Segale, Lorena
EQ-5D-5L Population Norms for Italy
2023-01-01 Meregaglia, Michela; Malandrini, Francesco; Finch, Aureliano Paolo; Ciani, Oriana; Jommi, Claudio
Do France, Germany, and Italy agree on the added therapeutic value of medicines?
2023-01-01 Casilli, Giorgio; Lidonnici, Dario; Jommi, Claudio; De Nigris, Marika; Genazzani, Armando
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries
2023-01-01 Canales Albendea, Miguel Á.; Canonico, Pier Luigi; Cartron, Guillaume; Deiters, Barthold; Jommi, Claudio; Marks, Reinhard; Rioufol, Catherine; Sancho Cia, Juan M.; Santoro, Armando; Wagner-Drouet, Eva M.
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency
2023-01-01 Jommi, Claudio; Galeone, Carlotta
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care
2023-01-01 Vingiani, Andrea; Agnelli, Luca; Duca, Matteo; Lorenzini, Daniele; Damian, Silvia; Proto, Claudia; Niger, Monica; Nichetti, Federico; Tamborini, Elena; Perrone, Federica; Piccolo, Alberta; Manoukian, Siranoush; Azzollini, Jacopo; Brambilla, Marta; Colombo, Elena; Lopez, Salvatore; Vernieri, Claudio; Marra, Francesca; Conca, Elena; Busico, Adele; Capone, Iolanda; Bozzi, Fabio; Angelini, Marta; Devecchi, Andrea; Salvatori, Rebecca; De Micheli, Valentina; Baggi, Anna; Pasini, Silvia; Jommi, Claudio; Ladisa, Vito; Apolone, Giovanni; De Braud, Filippo; Pruneri, Giancarlo
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
2023-01-01 Drummond, Michael; Ciani, Oriana; Fornaro, Giulia; Jommi, Claudio; Dietrich, Eva Susanne; Espin, Jaime; Mossman, Jean; de Pouvourville, Gerard
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
2023-01-01 Tarantola, A.; Otto, M. H.; Armeni, P.; Costa, F.; Malandrini, F.; Jommi, C.
Vitiligo: Unmet Need, Management and Treatment Guidelines
2023-01-01 Marzano, Angelo Valerio; Alberti-Violetti, Silvia; Maronese, Carlo Alberto; Avallone, Gianluca; Jommi, Claudio
Price and reimbursement of medicines when new indications are approved: the results of a survey on ISPOR Italy Rome Chapter members
2023-01-01 Di Brino, Eugenio; Jommi, Claudio
Unmet need: definitions, literature evidence and implications for HTA
2023-01-01 Jommi, Claudio; Meregaglia, Michela; Pinto, Carmine
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel | 1-gen-2024 | Jommi, Claudio; Patarnello, Francesca; Bianchi, Cosetta; Buzzetti, Giuliano | |
| Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy | 1-gen-2024 | Bolcato, Matteo; Jommi, Claudio | |
| Regional Formularies in Italy: current state and future perspectives | 1-gen-2024 | Bortolami, Alberto; Jommi, Claudio; Bresciani, Filippo; Piccoli, Luca; Sangiorgi, Elisa; Scroccaro, Giovanna | |
| Content validity of the EQ-HWB and EQ-HWB-S in a sample of Italian patients, informal caregivers and members of the general public | 1-gen-2024 | Masutti, Sara; Falivena, Camilla; Purba, Fredrick Dermawan; Jommi, Claudio; Mukuria, Clara; Finch, Aureliano Paolo | |
| From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy | 1-gen-2024 | Rossini, Elvio Emanuele; Galeone, Carlotta; Lucchetti, Chiara; Jommi, Claudio | |
| Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study | 1-gen-2024 | Cavallo, Maria Caterina; Cavazza, Marianna; Bonifazi, Francesca; Casadei, Beatrice; Cutini, Ilaria; Tonietti, Barbara; Saccardi, Riccardo; Zinzani, Pierluigi; Jommi, Claudio | |
| Early access programs for medicines: a reform proposal for the Italian National Health Service | 1-gen-2024 | Popoli, Patrizia; Giuliani, Giovanni; Cavaliere, Arturo; Jommi, Claudio | |
| The economic impact of 14 compassionate use programs for medicines in Italy, in the perspective of the National Health Service | 1-gen-2024 | Jommi, Claudio; Pantellini, Federico; Giuliani, Giovanni; Cavazza, Marianna | |
| Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe | 1-gen-2023 | Jommi, Claudio; Bertolani, Arianna; Armeni, Patrizio; Costa, Francesco; Otto, Monica | |
| Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access | 1-gen-2023 | Giovannelli, Lorella; Bari, Elia; Jommi, Claudio; Tartara, Fulvio; Armocida, Daniele; Garbossa, Diego; Cofano, Fabio; Torre, Maria Luisa; Segale, Lorena | |
| EQ-5D-5L Population Norms for Italy | 1-gen-2023 | Meregaglia, Michela; Malandrini, Francesco; Finch, Aureliano Paolo; Ciani, Oriana; Jommi, Claudio | |
| Do France, Germany, and Italy agree on the added therapeutic value of medicines? | 1-gen-2023 | Casilli, Giorgio; Lidonnici, Dario; Jommi, Claudio; De Nigris, Marika; Genazzani, Armando | |
| Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries | 1-gen-2023 | Canales Albendea, Miguel Á.; Canonico, Pier Luigi; Cartron, Guillaume; Deiters, Barthold; Jommi, Claudio; Marks, Reinhard; Rioufol, Catherine; Sancho Cia, Juan M.; Santoro, Armando; Wagner-Drouet, Eva M. | |
| The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency | 1-gen-2023 | Jommi, Claudio; Galeone, Carlotta | |
| Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care | 1-gen-2023 | Vingiani, Andrea; Agnelli, Luca; Duca, Matteo; Lorenzini, Daniele; Damian, Silvia; Proto, Claudia; Niger, Monica; Nichetti, Federico; Tamborini, Elena; Perrone, Federica; Piccolo, Alberta; Manoukian, Siranoush; Azzollini, Jacopo; Brambilla, Marta; Colombo, Elena; Lopez, Salvatore; Vernieri, Claudio; Marra, Francesca; Conca, Elena; Busico, Adele; Capone, Iolanda; Bozzi, Fabio; Angelini, Marta; Devecchi, Andrea; Salvatori, Rebecca; De Micheli, Valentina; Baggi, Anna; Pasini, Silvia; Jommi, Claudio; Ladisa, Vito; Apolone, Giovanni; De Braud, Filippo; Pruneri, Giancarlo | |
| How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? | 1-gen-2023 | Drummond, Michael; Ciani, Oriana; Fornaro, Giulia; Jommi, Claudio; Dietrich, Eva Susanne; Espin, Jaime; Mossman, Jean; de Pouvourville, Gerard | |
| Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case | 1-gen-2023 | Tarantola, A.; Otto, M. H.; Armeni, P.; Costa, F.; Malandrini, F.; Jommi, C. | |
| Vitiligo: Unmet Need, Management and Treatment Guidelines | 1-gen-2023 | Marzano, Angelo Valerio; Alberti-Violetti, Silvia; Maronese, Carlo Alberto; Avallone, Gianluca; Jommi, Claudio | |
| Price and reimbursement of medicines when new indications are approved: the results of a survey on ISPOR Italy Rome Chapter members | 1-gen-2023 | Di Brino, Eugenio; Jommi, Claudio | |
| Unmet need: definitions, literature evidence and implications for HTA | 1-gen-2023 | Jommi, Claudio; Meregaglia, Michela; Pinto, Carmine |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile